252 related articles for article (PubMed ID: 23092970)
1. SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage.
Lee SW; Lee MH; Park JH; Kang SH; Yoo HM; Ka SH; Oh YM; Jeon YJ; Chung CH
EMBO J; 2012 Nov; 31(23):4441-52. PubMed ID: 23092970
[TBL] [Abstract][Full Text] [Related]
2. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
Moumen A; Masterson P; O'Connor MJ; Jackson SP
Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
[TBL] [Abstract][Full Text] [Related]
3. DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation.
Pelisch F; Pozzi B; Risso G; Muñoz MJ; Srebrow A
J Biol Chem; 2012 Aug; 287(36):30789-99. PubMed ID: 22825850
[TBL] [Abstract][Full Text] [Related]
4. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
5. The SUMO (Small Ubiquitin-like Modifier) Ligase PIAS3 Primes ATR for Checkpoint Activation.
Wu CS; Zou L
J Biol Chem; 2016 Jan; 291(1):279-90. PubMed ID: 26565033
[TBL] [Abstract][Full Text] [Related]
6. Arginine methylation of hnRNP K enhances p53 transcriptional activity.
Chen Y; Zhou X; Liu N; Wang C; Zhang L; Mo W; Hu G
FEBS Lett; 2008 May; 582(12):1761-5. PubMed ID: 18472002
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage.
Gibbs-Seymour I; Oka Y; Rajendra E; Weinert BT; Passmore LA; Patel KJ; Olsen JV; Choudhary C; Bekker-Jensen S; Mailand N
Mol Cell; 2015 Jan; 57(1):150-64. PubMed ID: 25557546
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation of RORalpha potentiates transcriptional activation function.
Hwang EJ; Lee JM; Jeong J; Park JH; Yang Y; Lim JS; Kim JH; Baek SH; Kim KI
Biochem Biophys Res Commun; 2009 Jan; 378(3):513-7. PubMed ID: 19041634
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of TIP60 sumoylation in UV-irradiated DNA damage response.
Cheng Z; Ke Y; Ding X; Wang F; Wang H; Wang W; Ahmed K; Liu Z; Xu Y; Aikhionbare F; Yan H; Liu J; Xue Y; Yu J; Powell M; Liang S; Wu Q; Reddy SE; Hu R; Huang H; Jin C; Yao X
Oncogene; 2008 Feb; 27(7):931-41. PubMed ID: 17704809
[TBL] [Abstract][Full Text] [Related]
10. Regulation of REGγ cellular distribution and function by SUMO modification.
Wu Y; Wang L; Zhou P; Wang G; Zeng Y; Wang Y; Liu J; Zhang B; Liu S; Luo H; Li X
Cell Res; 2011 May; 21(5):807-16. PubMed ID: 21445096
[TBL] [Abstract][Full Text] [Related]
11. Mitotic kinase Aurora-B is regulated by SUMO-2/3 conjugation/deconjugation during mitosis.
Ban R; Nishida T; Urano T
Genes Cells; 2011 Jun; 16(6):652-69. PubMed ID: 21554500
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
[TBL] [Abstract][Full Text] [Related]
13. Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein.
Sundvall M; Korhonen A; Vaparanta K; Anckar J; Halkilahti K; Salah Z; Aqeilan RI; Palvimo JJ; Sistonen L; Elenius K
J Biol Chem; 2012 Jun; 287(27):23216-26. PubMed ID: 22584572
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress-induced p53 activity is enhanced by a redox-sensitive TP53INP1 SUMOylation.
Peuget S; Bonacci T; Soubeyran P; Iovanna J; Dusetti NJ
Cell Death Differ; 2014 Jul; 21(7):1107-18. PubMed ID: 24608790
[TBL] [Abstract][Full Text] [Related]
15. Expression levels of hnRNP K and p21WAF1/CIP1 are associated with resistance to radiochemotherapy independent of p53 pathway activation in rectal adenocarcinoma.
Daskalaki W; Wardelmann E; Port M; Stock K; Steinestel J; Huss S; Sperveslage J; Steinestel K; Eder S
Int J Mol Med; 2018 Dec; 42(6):3269-3277. PubMed ID: 30272263
[TBL] [Abstract][Full Text] [Related]
16. Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.
Park JH; Lee SW; Yang SW; Yoo HM; Park JM; Seong MW; Ka SH; Oh KH; Jeon YJ; Chung CH
Nat Commun; 2014 Nov; 5():5483. PubMed ID: 25406032
[TBL] [Abstract][Full Text] [Related]
17. SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination.
Lee MH; Lee SW; Lee EJ; Choi SJ; Chung SS; Lee JI; Cho JM; Seol JH; Baek SH; Kim KI; Chiba T; Tanaka K; Bang OS; Chung CH
Nat Cell Biol; 2006 Dec; 8(12):1424-31. PubMed ID: 17086174
[TBL] [Abstract][Full Text] [Related]
18. PIAS1-mediated sumoylation promotes STUbL-dependent proteasomal degradation of the human telomeric protein TRF2.
Her J; Jeong YY; Chung IK
FEBS Lett; 2015 Oct; 589(21):3277-86. PubMed ID: 26450775
[TBL] [Abstract][Full Text] [Related]
19. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53.
Zhou R; Shanas R; Nelson MA; Bhattacharyya A; Shi J
Int J Cancer; 2010 Jan; 126(2):395-404. PubMed ID: 19609950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
